Ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate
C11H12N2O3 — CID 58680035
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate
Ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate (PubChem CID 58680035) has the molecular formula C11H12N2O3 and a molecular weight of 220.23 g/mol. Its IUPAC name is ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate.
Molecular Properties
| Compound Name | Ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate |
|---|---|
| PubChem CID | 58680035 |
| Molecular Formula | C11H12N2O3 |
| Molecular Weight | 220.23 g/mol |
| Exact Mass | 220.08 |
| IUPAC Name | ethyl (Z)-2-[(Z)-1-cyano-1-isocyanoprop-1-en-2-yl]-3-hydroxybut-2-enoate |
| SMILES | [C-]#[N+]/C(C#N)=C(C)\C(C(=O)OCC)=C(/C)O |
| InChI | InChI=1S/C11H12N2O3/c1-5-16-11(15)10(8(3)14)7(2)9(6-12)13-4/h14H,5H2,1-3H3/b9-7-,10-8- |
| InChIKey | LOWDDMDUFKJPPD-XOHWUJONSA-N |
| XLogP | 2.10 |
| TPSA | 74.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 220.23 |
| LogP ≤ 5 | 2.10 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58680035 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.